User profiles for Enrico Munari

Enrico Munari

Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy
Verified email at unibs.it
Cited by 5183

Human NK cells: surface receptors, inhibitory checkpoints, and translational applications

S Sivori, P Vacca, G Del Zotto, E Munari… - Cellular & molecular …, 2019 - nature.com
NK cells play important roles in innate defenses against viruses and in the control of tumor
growth and metastasis. The regulation/induction of NK cell function is mediated by an array of …

[HTML][HTML] Killer Ig-like receptors (KIRs): their role in NK cell modulation and developments leading to their clinical exploitation

…, M Vitale, C Cantoni, C Vitale, E Munari… - Frontiers in …, 2019 - frontiersin.org
Natural killer (NK) cells contribute to the first line of defense against viruses and to the control
of tumor growth and metastasis spread. The discovery of HLA class I specific inhibitory …

TERT Promoter Mutations Occur Early in Urothelial Neoplasia and Are Biomarkers of Early Disease and Disease Recurrence in Urine

I Kinde, E Munari, SF Faraj, RH Hruban, M Schoenberg… - Cancer research, 2013 - AACR
Activating mutations occur in the promoter of the telomerase reverse transcriptase (TERT)
gene in 66% of muscle-invasive urothelial carcinomas. To explore their role in bladder cancer …

18F-DCFBC PET/CT for PSMA-based detection and characterization of primary prostate cancer

…, N Gonzalez-Roibon, G Guner, E Munari… - Journal of Nuclear …, 2015 - Soc Nuclear Med
We previously demonstrated the ability to detect metastatic prostate cancer using N-[N-[(S)-1,3-dicarboxypropyl]carbamoyl]-4-
18 F-fluorobenzyl-l-cysteine ( 18 F-DCFBC), a low-…

[HTML][HTML] Characterization of human NK cell-derived exosomes: role of DNAM1 receptor in exosome-mediated cytotoxicity against tumor

…, N Tumino, F Besi, C Alicata, LA Conti, E Munari… - Cancers, 2020 - mdpi.com
Despite the pivotal role of natural killer (NK) cells in defenses against tumors, their exploitation
in cancer treatment is still limited due to their reduced ability to reaching tumor sites and …

[HTML][HTML] “Interchangeability” of PD-L1 immunohistochemistry assays: a meta-analysis of diagnostic accuracy

…, G Han, FR Hirsch, M Ilie, D Ionescu, C Li, E Munari… - Modern Pathology, 2020 - Elsevier
Different clones, protocol conditions, instruments, and scoring/readout methods may pose
challenges in introducing different PD-L1 assays for immunotherapy. The diagnostic accuracy …

Assessment of tumoral PD-L1 expression and intratumoral CD8+ T cells in urothelial carcinoma

SF Faraj, E Munari, G Guner, J Taube, R Anders… - Urology, 2015 - Elsevier
Objective To evaluate programmed death ligand 1 (PD-L1) expression in urothelial carcinoma
of the bladder in relationship with tumor-infiltrating CD8+ T cells. Materials and Methods …

[HTML][HTML] PD-L1 expression heterogeneity in non–small cell lung cancer: defining criteria for harmonization between biopsy specimens and whole sections

E Munari, G Zamboni, G Lunardi, L Marchionni… - Journal of Thoracic …, 2018 - Elsevier
Introduction Determination of programmed death ligand 1 (PD-L1) expression defines
eligibility for treatment with pembrolizumab in patients with advanced NSCLC. This study was …

[HTML][HTML] PD-1/PD-L1 in cancer: pathophysiological, diagnostic and therapeutic aspects

E Munari, FR Mariotti, L Quatrini, P Bertoglio… - International journal of …, 2021 - mdpi.com
Immune evasion is a key strategy adopted by tumor cells to escape the immune system while
promoting their survival and metastatic spreading. Indeed, several mechanisms have been …

[HTML][HTML] The immune checkpoint PD-1 in natural killer cells: expression, function and targeting in tumour immunotherapy

L Quatrini, FR Mariotti, E Munari, N Tumino, P Vacca… - Cancers, 2020 - mdpi.com
Simple Summary Natural killer cells are innate cytotoxic lymphocytes that play a key role in
the anti-tumor immune response. In the tumor microenvironment, however, the effector …